Stephanie Stehman joined OUP in 2015 and focuses on investments in therapeutics, diagnostics, and medical devices. Previously, Stephanie was with H.I.G. BioVentures, a venture capital firm that makes investments in the life sciences sector.
Earlier in her career, Stephanie was a Senior Consultant with Scisive Consulting, a strategy consulting firm for healthcare businesses. At Scisive, she worked with a wide range of medical industry clients to provide strategic, financial, and business development support.
Stephanie earned her Ph.D. in Cell Biology from Columbia University where she studied the role of molecular motor proteins in cell division and holds a B.S. in Biology from Muhlenberg College.